What are the major opportunities in the Cellular Immunotherapy market? What are the strategies for the Cellular Immunotherapy market?

For detailed insights on the major opportunities and strategies in the Cellular Immunotherapy market, Read More

How does the Cellular Immunotherapy market relate to the overall economy and other similar markets?

For detailed insights on Cellular Immunotherapy's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Cellular Immunotherapy market growth? SWOT analysis of the Cellular Immunotherapy market.

For detailed insights on the key dynamics influencing the Cellular Immunotherapy market growth and SWOT analysis of the Cellular Immunotherapy industry, Read More

Cellular Immunotherapy Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Cellular Immunotherapy Market Report 2026

Name: Cellular Immunotherapy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy ), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cellular Immunotherapy Market Overview

• Cellular Immunotherapy market size has reached to $6.56 billion in 2025

• Expected to grow to $12.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%

• Growth Driver: Role Of Cellular Immunotherapies In Addressing Rising Prevalence

• Market Trend: Major Companies Drive Innovation in Cellular Immunotherapy for Enhanced Treatment Efficacy

• North America was the largest region in 2025.

What Is Covered Under Cellular Immunotherapy Market?

Cellular immunotherapy refers to a sort of immunotherapy in which a patient receives T cells, an immune cell, to aid the body in fighting diseases like cancer. It is a cutting-edge kind of treatment that uses the body's immune system to combat cancer.

The main therapies of cellular immunotherapy are tumor-infiltrating lymphocyte (TIL) therapy, engineered T cell receptor (TCR) therapy, chimeric antigen receptor (CAR) T cell therapy, and natural killer (NK) cell therapy. Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy that involves extracting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro, and then infusing them back into patients to treat them. The various primary indications include b-cell malignancies, prostate cancer, renal cell carcinoma, liver cancer, non-Hodgkin lymphoma, and others, and are used for the treatment of prostate cancer, breast cancer, skin cancer, ovarian cancer, brain tumors, lung cancer, and others.

Cellular Immunotherapy Market Global Report 2026 Market Report bar graph

What Is The Cellular Immunotherapy Market Size and Share 2026?

The cellular immunotherapy market size has grown rapidly in recent years. It will grow from $6.56 billion in 2025 to $7.48 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to success of early car-t therapies, unmet oncology needs, research funding growth, regulatory approvals, academic-industry collaboration.

What Is The Cellular Immunotherapy Market Growth Forecast?

The cellular immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $12.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to expansion into solid tumors, innovation in nk cell therapy, scalable manufacturing technologies, supportive regulatory frameworks, increased oncology investment. Major trends in the forecast period include rapid growth of car-t cell therapies, expansion of allogeneic cell therapies, increasing use in hematologic malignancies, advancements in t cell engineering, rising clinical trial activity.

Book your 30 minutes free consultation with our research experts

Global Cellular Immunotherapy Market Segmentation

1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy

2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications

3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

Subsegments:

1) By Tumour-Infiltrating Lymphocyte (TIL) Therapy: Autologous TIL Therapy, Allogeneic TIL Therapy

2) By Engineered T Cell Receptor (TCR) Therapy: Alpha-Beta TCR Therapy, Gamma-Delta TCR Therapy

3) By Chimeric Antigen Receptor (CAR) T Cell Therapy: Autologous CAR T Cell Therapy, Allogeneic CAR T Cell Therapy, CAR T Cell Therapy For Solid Tumors, CAR T Cell Therapy For Hematologic Malignancies

4) By Natural Killer (NK) Cell Therapy: Autologous NK Cell Therapy, Allogeneic NK Cell Therapy, NK Cell Therapy With Engineered Modifications

What Is The Driver Of The Cellular Immunotherapy Market?

The rising prevalence of cancer is expected to propel the growth of the cellular immunotherapy market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising prevalence of cancer is largely due to an aging population, lifestyle factors, and improved screening and diagnosis. Environmental exposures and genetic predispositions also play significant roles in increasing incidence rates. Cellular immunotherapy boosts the immune response against cancer by specifically targeting tumor cells, improving survival rates. This approach, combined with other treatments, may lead to a decrease in cancer incidence and recurrence. For instance, in March 2024, according to MAC Clinical Research, a UK-based cancer research organization, the estimated number of people living with cancer in the United Kingdom is expected to increase from about 3 million currently to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising prevalence of cancer is driving the growth of the cellular immunotherapy industry.

Key Players In The Global Cellular Immunotherapy Market

Major companies operating in the cellular immunotherapy market are Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego Corporation

Global Cellular Immunotherapy Market Trends and Insights

Major companies operating in the cellular immunotherapy market are focused on developing technological advancements such as immunotherapy. To enhance treatment efficacy and expand applications. Their focus includes personalized medicine, combination therapies, and scalable manufacturing to improve patient outcomes. Immunotherapy is a treatment that harnesses the body’s immune system to fight diseases, especially cancer. It can involve boosting immune responses or providing targeted therapies to enhance immune activity against specific cells. For instance, in December 2023, Max Healthcare Institute Limited is an India-based healthcare service provider company. CAR-T cell therapy is a revolutionary cancer treatment that utilizes genetically engineered T cells to specifically target and destroy cancer cells, offering a personalized approach. It provides durable remission rates, particularly for resistant blood cancers, while minimizing damage to healthy tissues.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Cellular Immunotherapy Market?

In January 2023, AstraZeneca., a UK-based pharmaceutical industry company, acquired Neogene Therapeutics for an undisclosed amount. With this acquisition, AstraZeneca aims to enhance its oncology portfolio and accelerate the development of innovative T-cell receptor therapies for solid tumours through its acquisition of Neogene Therapeutics. Neogene Therapeutics, Inc., a US-based biotechnology company. It specializes in personalized cellular immunotherapy, designing T-cells to specifically target cancer cells.

Regional Insights

North America was the largest region in the cellular immunotherapy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cellular Immunotherapy Market?

The cellular immunotherapy market includes revenues earned by entities by inventing, developing, administering, and understanding engineered immune effector cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cellular Immunotherapy Market Report 2026?

The cellular immunotherapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cellular immunotherapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Cellular Immunotherapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$7.48 billion
Revenue Forecast In 2035	$12.5 billion
Growth Rate	CAGR of 14.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapy, Primary Indication, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Ce
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cellular Immunotherapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cellular Immunotherapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cellular Immunotherapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cellular Immunotherapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rapid Growth Of Car-T Cell Therapies

4.2.2 Expansion Of Allogeneic Cell Therapies

4.2.3 Increasing Use In Hematologic Malignancies

4.2.4 Advancements In T Cell Engineering

4.2.5 Rising Clinical Trial Activity

5. Cellular Immunotherapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Treatment Centers

5.3 Specialty Oncology Clinics

5.4 Academic Medical Centers

5.5 Clinical Research Institutes

6. Cellular Immunotherapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cellular Immunotherapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cellular Immunotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cellular Immunotherapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cellular Immunotherapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cellular Immunotherapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cellular Immunotherapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cellular Immunotherapy Market Segmentation

9.1. Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy

9.2. Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications

9.3. Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

9.4. Global Cellular Immunotherapy Market, Sub-Segmentation Of Tumour-Infiltrating Lymphocyte (TIL) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autologous TIL Therapy, Allogeneic TIL Therapy

9.5. Global Cellular Immunotherapy Market, Sub-Segmentation Of Engineered T Cell Receptor (TCR) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alpha-Beta TCR Therapy, Gamma-Delta TCR Therapy

9.6. Global Cellular Immunotherapy Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autologous CAR T Cell Therapy, Allogeneic CAR T Cell Therapy, CAR T Cell Therapy For Solid Tumors, CAR T Cell Therapy For Hematologic Malignancies

9.7. Global Cellular Immunotherapy Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autologous NK Cell Therapy, Allogeneic NK Cell Therapy, NK Cell Therapy With Engineered Modifications

10. Cellular Immunotherapy Market Regional And Country Analysis

10.1. Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cellular Immunotherapy Market

11.1. Asia-Pacific Cellular Immunotherapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cellular Immunotherapy Market

12.1. China Cellular Immunotherapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cellular Immunotherapy Market

13.1. India Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cellular Immunotherapy Market

14.1. Japan Cellular Immunotherapy Market Overview

14.2. Japan Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cellular Immunotherapy Market

15.1. Australia Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cellular Immunotherapy Market

16.1. Indonesia Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cellular Immunotherapy Market

17.1. South Korea Cellular Immunotherapy Market Overview

17.2. South Korea Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cellular Immunotherapy Market

18.1. Taiwan Cellular Immunotherapy Market Overview

18.2. Taiwan Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cellular Immunotherapy Market

19.1. South East Asia Cellular Immunotherapy Market Overview

19.2. South East Asia Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cellular Immunotherapy Market

20.1. Western Europe Cellular Immunotherapy Market Overview

20.2. Western Europe Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cellular Immunotherapy Market

21.1. UK Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cellular Immunotherapy Market

22.1. Germany Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cellular Immunotherapy Market

23.1. France Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cellular Immunotherapy Market

24.1. Italy Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cellular Immunotherapy Market

25.1. Spain Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cellular Immunotherapy Market

26.1. Eastern Europe Cellular Immunotherapy Market Overview

26.2. Eastern Europe Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cellular Immunotherapy Market

27.1. Russia Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cellular Immunotherapy Market

28.1. North America Cellular Immunotherapy Market Overview

28.2. North America Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cellular Immunotherapy Market

29.1. USA Cellular Immunotherapy Market Overview

29.2. USA Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cellular Immunotherapy Market

30.1. Canada Cellular Immunotherapy Market Overview

30.2. Canada Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cellular Immunotherapy Market

31.1. South America Cellular Immunotherapy Market Overview

31.2. South America Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cellular Immunotherapy Market

32.1. Brazil Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cellular Immunotherapy Market

33.1. Middle East Cellular Immunotherapy Market Overview

33.2. Middle East Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cellular Immunotherapy Market

34.1. Africa Cellular Immunotherapy Market Overview

34.2. Africa Cellular Immunotherapy Market, Segmentation By Therapy, Segmentation By Primary Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cellular Immunotherapy Market Regulatory and Investment Landscape

36. Cellular Immunotherapy Market Competitive Landscape And Company Profiles

36.1. Cellular Immunotherapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cellular Immunotherapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cellular Immunotherapy Market Company Profiles

36.3.1. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Apac Biotech Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Dendreon Pharmaceuticals LLC Overview, Products and Services, Strategy and Financial Analysis

36.3.5. JW CreaGene Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Cellular Immunotherapy Market Other Major And Innovative Companies

Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc.

38. Global Cellular Immunotherapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cellular Immunotherapy Market

40. Cellular Immunotherapy Market High Potential Countries, Segments and Strategies

40.1 Cellular Immunotherapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Cellular Immunotherapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Cellular Immunotherapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Cellular Immunotherapy Market, Overview Of Key Products - Product Examples

Table 2: Global Cellular Immunotherapy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Cellular Immunotherapy Market, Supply Chain Analysis

Table 4: Global Cellular Immunotherapy Market, Major Raw Material Providers

Table 5: Global Cellular Immunotherapy Market, Major Resource Providers

Table 6: Global Cellular Immunotherapy Market, Major Manufacturers (Suppliers)

Table 7: Global Cellular Immunotherapy Market, Major Distributors And Channel Partners

Table 8: Global Cellular Immunotherapy Market, Key Technologies & Future Trends

Table 9: Global Cellular Immunotherapy Market, Major Trends

Table 10: Global Cellular Immunotherapy Market, Major End Users

Table 11: Global Cellular Immunotherapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Cellular Immunotherapy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Cellular Immunotherapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Cellular Immunotherapy Market - TAM, US$ Billion, 2025

Table 15: Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Cellular Immunotherapy Market, Sub-Segmentation Of Tumour-Infiltrating Lymphocyte (TIL) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Cellular Immunotherapy Market, Sub-Segmentation Of Engineered T Cell Receptor (TCR) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Cellular Immunotherapy Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Cellular Immunotherapy Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Cellular Immunotherapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Cellular Immunotherapy Market - Company Scoring Matrix

Table 98: Novartis International AG Financial Performance

Table 99: Gilead Sciences Inc. Financial Performance

Table 100: Apac Biotech Financial Performance

Table 101: Dendreon Pharmaceuticals LLC Financial Performance

Table 102: JW CreaGene Co. Ltd Financial Performance

Table 103: Global Cellular Immunotherapy Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Cellular Immunotherapy Market, Competitive Dashboard

Table 105: Global Cellular Immunotherapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Cellular Immunotherapy Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Table 107: Global, Cellular Immunotherapy Market Size Gain ($ Billion), Segmentation By Primary Indication, 2025 – 2030

Table 108: Global, Cellular Immunotherapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Cellular Immunotherapy Market, Overview Of Key Products - Product Examples

Figure 2: Global Cellular Immunotherapy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Cellular Immunotherapy Market, Supply Chain Analysis

Figure 4: Global Cellular Immunotherapy Market, Major Raw Material Providers

Figure 5: Global Cellular Immunotherapy Market, Major Resource Providers

Figure 6: Global Cellular Immunotherapy Market, Major Manufacturers (Suppliers)

Figure 7: Global Cellular Immunotherapy Market, Major Distributors And Channel Partners

Figure 8: Global Cellular Immunotherapy Market, Key Technologies & Future Trends

Figure 9: Global Cellular Immunotherapy Market, Major Trends

Figure 10: Global Cellular Immunotherapy Market, Major End Users

Figure 11: Global Cellular Immunotherapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Cellular Immunotherapy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Cellular Immunotherapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Cellular Immunotherapy Market - TAM, US$ Billion, 2025

Figure 15: Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Cellular Immunotherapy Market, Sub-Segmentation Of Tumour-Infiltrating Lymphocyte (TIL) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Cellular Immunotherapy Market, Sub-Segmentation Of Engineered T Cell Receptor (TCR) Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Cellular Immunotherapy Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Cellular Immunotherapy Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Cellular Immunotherapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Cellular Immunotherapy Market - Company Scoring Matrix

Figure 98: Novartis International AG Financial Performance

Figure 99: Gilead Sciences Inc. Financial Performance

Figure 100: Apac Biotech Financial Performance

Figure 101: Dendreon Pharmaceuticals LLC Financial Performance

Figure 102: JW CreaGene Co. Ltd Financial Performance

Figure 103: Global Cellular Immunotherapy Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Cellular Immunotherapy Market, Competitive Dashboard

Figure 105: Global Cellular Immunotherapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Cellular Immunotherapy Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Figure 107: Global, Cellular Immunotherapy Market Size Gain ($ Billion), Segmentation By Primary Indication, 2025 – 2030

Figure 108: Global, Cellular Immunotherapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

Latest Market Developments in Specialty Generics Industry: Forecast 2025–2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Cancer Immunotherapy Market Report 2026 - Global Outlook – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cance...

Allergy Immunotherapy Market Report 2026 - Global Outlook – By Allergy Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Venom Allergy, Allergic Conjunctivitis, Environmental Allergies), By Treatment (Subcutaneous ...

Cell Therapy Market Report 2026 - Global Outlook – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy ), By Therapy Type (Allogeneic Therapies, ...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Immunohematology Market Report 2026 - Global Outlook – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PC...

Cell Therapy Technologies Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cell Types), By Process (Cell Processing, Cell Preservat...

Immunomodulator Market Report 2026 - Global Outlook – By Product Type (Immunosuppressants, Immunostimulants, Other Product Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distr...

Frequently Asked Questions

How big is the Cellular Immunotherapy Market?

The Cellular Immunotherapy market was valued at $6.56 billion in 2025, increased to $7.48 billion in 2026, and is projected to reach $12.5 billion by 2030. request a sample here

What is the Cellular Immunotherapy market growth?

The global Cellular Immunotherapy market is expected to grow at a CAGR of 13.7% from 2026 to 2035 to reach $12.5 billion by 2035. request a sample here

Who are the key players in Cellular Immunotherapy market?

Some Key Players in the Cellular Immunotherapy market Include, Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego Corporation . request a sample here

What is the anticipated growth trend for the Cellular Immunotherapy market?

Major trend in this market includes: Major Companies Drive Innovation in Cellular Immunotherapy for Enhanced Treatment Efficacy. For further insights on this market. request a sample here

Which region has the most growth potential in the Cellular Immunotherapy market?

North America was the largest region in the cellular immunotherapy market in 2025. The regions covered in the cellular immunotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Cellular Immunotherapy Market Report 2026 market?

Major companies operating in the Cellular Immunotherapy Market Report 2026 market are Major companies operating in the cellular immunotherapy market are Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW Cre request a sample here.

Book your 30 minutes free consultation with our research experts

Contact Us